EPICS Therapeutics vs Reborna Biosciences, Inc.

EPICS Therapeutics logo

EPICS Therapeutics

EPICS is a drug discovery and development company for small molecule drugs targeting RNA epigenetic mecanisms of cancer

30 employees · est. 2018 · Belgium

VS
Reborna Biosciences, Inc. logo

Reborna Biosciences, Inc.

Save the life of rare disease patients and the parents by RNA binding molecules

7 employees · est. 2018 · Fujisawa, Japan

EPICS Therapeutics is the larger of the two.

Side-by-Side Comparison

EPICS Therapeutics Reborna Biosciences, Inc.
Founded
2018 2018
Headquarters
Belgium Fujisawa, Japan
Employees
30 larger 7
Industry
Biopharma, Health Care Biotechnology, Health Care
Funding Stage
Seed Seed
Total Funding
$7.20M $256.00M
Funding Rounds
1 1
Taxonomy
Drug DeliveryCancer TherapeuticsRNA EpigeneticsSmall Molecule DrugsOncology Research RNA-targeting Small Molecule DrugsGenetic DiseasesRare Disease PatientsTherapeutic DrugsRNA Binding MoleculesRare Genetic Diseases +7
Website
epicstherapeutics.com rebornabiosciences.com
EPICS Therapeutics logo

About EPICS Therapeutics

Epic Therapeutics is a biopharmaceutical startup based in Belgium, founded in 2018. The company is focused on developing small molecule drugs targeting RNA epigenetic mechanisms involved in cancer. Its mission is to address unmet medical needs in oncology by inventing novel clinical agents. The rece...

Reborna Biosciences, Inc. logo

About Reborna Biosciences, Inc.

Reborna Biosciences, Inc. is a Japan-based startup established in 2018 with a focus on developing RNA-targeting small molecule drugs for rare genetic diseases. Their proprietary screening method aims to identify orally available small molecules by replicating the natural three-dimensional structure...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches EPICS Therapeutics and Reborna Biosciences, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when EPICS Therapeutics or Reborna Biosciences, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

EPICS Therapeutics was founded in 2018, based in Belgium, with 30 employees. Epic Therapeutics is a biopharmaceutical startup based in Belgium, founded in 2018. The company is focused on developing small molecule drugs targeting RNA epigenetic mechanisms involved in cancer. It. Reborna Biosciences, Inc. was founded in 2018, based in Fujisawa, Japan, with 7 employees. Reborna Biosciences, Inc. is a Japan-based startup established in 2018 with a focus on developing RNA-targeting small molecule drugs for rare genetic diseases. Their proprietary screening method aims.
EPICS Therapeutics has raised $7.20M and Reborna Biosciences, Inc. $256.00M. Latest stage: EPICS Therapeutics Seed, Reborna Biosciences, Inc. Seed.
Both work in Health Care.

Compare EPICS Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EPICS Therapeutics on 11 Sep 2024, and Reborna Biosciences, Inc. on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes